Skip to main content

Table 3 Variation in mean consumption and prevalence of excessive users (range and max-min ratio) between counties and correlations between mean consumption and prevalence of excessive users (>365 DDD/year; > 730 DDD/year) at county level

From: The total sale of prescription drugs with an abuse potential predicts the number of excessive users: a national prescription database study

 

Mean consumption per inhabitant

Prevalence w/ >365 DDD per 1000 population

Prevalence w/ >730 DDD per 1000 population

Correlations with mean consumption

 

range and max-min ratio

range and max-min ratio

range and max-min ratio

> 365 DDD Per 1000 inhabitants

> 730 DDD Per 1000 inhabitants

Carisoprodol

0.40 - 1.09

0.14-0.48

0.02-0.15

0.87**

0.52*

2.7

3.4

7.5

Codeine

2.92 - 6.76

1.26-3.56

0.25-0.60

0.97**

0.72**

2.3

2.8

2.4

Diazepam

2.05-5.99

1.20-3.91

0.20-0.81

0.95**

0.82**

2.9

3.3

4.0

Oxazepam

1.11-3.83

0.45-2.04

0.10-0.38

0.96**

0.85**

3.5

4.5

3.8

Nitrazepam

1.11-3.49

1.00-3.30

0.11-0.48

0.99**

0.85**

3.1

3.3

4.4

Flunitrazepam

0.43-1.41

0.36-1.29

0.05-0.37

0.97**

0.85**

3.3

3.6

7.4

Zopiclone

6.07-13.17

3.70-11.11

0.37-1.42

0.99**

0.87**

2.2

3.0

3.0

Zolpidem

0.65-1.62

0.44-1.23

0.03-0.22

0.95**

0.88**

2.5

2.8

7.3

Anxiolytics (including alprazolam)

3.87-10.84

2.12-7.10

0.60-2.17

0.98**

0.89**

2.8

3.3

3.6

Hypnotics (including clomethiazole)

8.32-18.23

5.86-16.61

0.66-2.50

0.99**

0.86**

2.2

2.8

3.8

All studied drugs

16.25-33.86

13.28-29.04

2.98-9.65

0.99**

0.95**

2.1

2.2

3.2

  1. Levels of statistical significance: *p < 0.05, **p < .01.